Penbrook Management LLC Regeneron Pharmaceuticals, Inc. Transaction History
Penbrook Management LLC
- $137 Million
- Q4 2024
A detailed history of Penbrook Management LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Penbrook Management LLC holds 897 shares of REGN stock, worth $604,820. This represents 0.46% of its overall portfolio holdings.
Number of Shares
897
Previous 1,147
21.8%
Holding current value
$604,820
Previous $1.21 Million
47.05%
% of portfolio
0.46%
Previous 0.83%
Shares
8 transactions
Others Institutions Holding REGN
# of Institutions
1,487Shares Held
83.4MCall Options Held
1.32MPut Options Held
1.52M-
Vanguard Group Inc Valley Forge, PA9.29MShares$6.26 Billion0.12% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$5.7 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY7.06MShares$4.76 Billion0.41% of portfolio
-
State Street Corp Boston, MA4.9MShares$3.31 Billion0.21% of portfolio
-
Capital International Investors Los Angeles, CA4.74MShares$3.19 Billion0.66% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $72.3B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...